Literature DB >> 2915224

Cryptococcosis in AIDS patients: observations concerning CNS involvement.

T Weinke1, G Rögler, C Sixt, B de Matos-Marques, H D Pohle, F Staib, M Seibold.   

Abstract

The clinical course and response to therapy of seven patients with cryptococcosis and AIDS were reviewed. One patient was still in the primary stage of cryptococcosis in AIDS, i.e. the stage that is characterized by the sole cultural detection of Cryptococcus neoformans in the respiratory tract. The other six patients were in the secondary stage, where C. neoformans can be detected from the cerebrospinal fluid (CSF), blood, urine, faeces and other body sites. The main presenting features (headache, fever, nausea) were due to central nervous system involvement, although meningism and mental changes were rarely present, and CSF changes were very subtle. Treatment with amphotericin B and flucytosine was very effective, there being no more growth of fungi in cultures in most cases. Adverse reactions to the drugs used occurred frequently and consisted mainly of anaemia, hepatosis and fever. Diagnosis in the primary stage of cryptococcosis may improve the prognosis.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2915224     DOI: 10.1007/BF00314216

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  41 in total

1.  [CRYPTOCOCCAL MENINGITIS. RECENT OBSERVATIONS ON DIAGNOSIS AND TREATMENT].

Authors:  J P UTZ; W T BUTLER
Journal:  Dtsch Med Wochenschr       Date:  1965-05-21       Impact factor: 0.628

2.  Fatal aplastic anemia resulting from flucytosine.

Authors:  R Meyer; J L Axelrod
Journal:  JAMA       Date:  1974-06-17       Impact factor: 56.272

3.  Amphotericin B toxicity. A follow-up report of 53 patients.

Authors:  R P Miller; J H Bates
Journal:  Ann Intern Med       Date:  1969-12       Impact factor: 25.391

4.  Amphotericin B in cryptococcal meningitis. Long-term results of treatment.

Authors:  G A Sarosi; J D Parker; I L Doto; F E Tosh
Journal:  Ann Intern Med       Date:  1969-12       Impact factor: 25.391

5.  Diagnosis of cryptococcal meningitis. Value of immunologic detection of cryptococcal antigen.

Authors:  J S Goodman; L Kaufman; M G Koenig
Journal:  N Engl J Med       Date:  1971-08-19       Impact factor: 91.245

6.  The brown colour effect (BCE) of Cryptococcus neoformans in the diagnosis, control and epidemiology of C. neoformans infections in AIDS patients.

Authors:  F Staib; M Seibold; E Antweiler; B Fröhlich; S Weber; A Blisse
Journal:  Zentralbl Bakteriol Mikrobiol Hyg A       Date:  1987-08

7.  Amphotericin B nephrotoxicity in humans decreased by salt repletion.

Authors:  H T Heidemann; J F Gerkens; W A Spickard; E K Jackson; R A Branch
Journal:  Am J Med       Date:  1983-09       Impact factor: 4.965

8.  [Chronic pulmonary cryptococcosis. A case contribution for diagnosis of cryptococcosis in man from a pathologic-anatomic viewpoint].

Authors:  G Grosse; F Niedobitek; M l'Age; F Staib
Journal:  Dtsch Med Wochenschr       Date:  1981-08-14       Impact factor: 0.628

9.  Cryptococcosis of the central nervous system. Epidemiological, clinical, and therapeutic features.

Authors:  V E Edwards; J M Sutherland; J H Tyrer
Journal:  J Neurol Neurosurg Psychiatry       Date:  1970-08       Impact factor: 10.154

10.  Treatment of cryptococcal meningitis with combination amphotericin B and flucytosine for four as compared with six weeks.

Authors:  W E Dismukes; G Cloud; H A Gallis; T M Kerkering; G Medoff; P C Craven; L G Kaplowitz; J F Fisher; C R Gregg; C A Bowles; S Shadomy; A M Stamm; R B Diasio; L Kaufman; S Soong; W C Blackwelder
Journal:  N Engl J Med       Date:  1987-08-06       Impact factor: 91.245

View more
  2 in total

1.  Cavitating pulmonary cryptococcosis developing in an HIV antibody patient despite prior treatment with fluconazole.

Authors:  R J Coker; D Bell; B S Peters; S M Murphy
Journal:  Genitourin Med       Date:  1992-02

2.  Comparison of commercial kits for detection of cryptococcal antigen.

Authors:  D C Tanner; M P Weinstein; B Fedorciw; K L Joho; J J Thorpe; L Reller
Journal:  J Clin Microbiol       Date:  1994-07       Impact factor: 5.948

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.